Antibiotics Rx icon
Classify Rx for pharmacology icon
Lab Values Pro: Lab reference icon
+4

Nishith Sekhar Revappala

7apps1.3(724) Multi-theme

Publisher DNA

What defines Nishith Sekhar Revappala?

AI intelligence is not yet available for Nishith Sekhar Revappala. The portfolio data below is up to date.

Portfolio

What does Nishith Sekhar Revappala ship?

Apps

7 apps analysed

Analysis in progress

Classify Rx for pharmacology icon
Classify Rx for pharmacology

A concise app to revise complete pharmacology

3.9(724)
View Intel →

Analysis in progress

Analysis in progress

Single-market publisher, every app ships only to United States.

Based on 2 of 7 apps with localized market data, more coverage rolling in as scans complete · last scanned .

Americas (1)

  • United States2 / 2

Core markets (2/2 apps)

United States

Frequently asked questions

How many apps does Nishith Sekhar Revappala publish?
Nishith Sekhar Revappala has 7 apps tracked by Marlvel, primarily in the Medical category.
What kind of apps does Nishith Sekhar Revappala make?
Nishith Sekhar Revappala's portfolio is concentrated in Medical and Medicina, with an average rating of 1.3/5 across rated apps.
What is Nishith Sekhar Revappala's top app?
By review volume across the portfolio, Classify Rx for pharmacology is Nishith Sekhar Revappala's best-known app tracked by Marlvel.
In how many countries are Nishith Sekhar Revappala's apps available?
Marlvel has tracked Nishith Sekhar Revappala's apps across 1 country.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Nishith Sekhar Revappala, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Cite this report

Marlvel.ai. “Nishith Sekhar Revappala intelligence.” Updated N/A. https://marlvel.ai/publishers/nishith-sekhar-revappala

See methodologyContact support

Data licensed under CC-BY-NC 4.0